GigaGen's mission is to empower basic and clinical researchers with cutting-edge technology to sequence and quantify dozens of transcripts across millions of single lymphocytes in a single experiment.
We are a talented team of bioinformaticians, microfluidics engineers, molecular biologists, and immunologists.
GigaGen is funded by grants from National Institutes of health and the National Science Foundation.
Now available as a research service.
The GigaMune® technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize an immune system into an immune "fingerprint".
Hundreds of single T or B cells per second are isolated into reaction compartments and then analyzed at key immune genes.
The resulting DNA libraries can then be used to express fully functional proteins for in vitro analysis.
Cell-Seq™ is a specialized platform that enables massively parallel single cell sequencing. GigaMune® is the first application for Cell-Seq™, but many applications are possible.
Future work will develop the technology for noninvasive molecular analysis of cancer, and even development of immune therapeutics.
Our first customers are clinical and basic researchers at leading universities studying immune function and disease. Contact us for information on collaborations.